Personalized medicine -- the ability to tailor therapies to patients' individual genetic characteristics -- has long been the holy grail of the life sciences industry. The effort has produced a string of recent successes, including European approval of the world's first gene therapy treatment. While exciting for patients, such advances raise a host of ethical, legal and financial challenges that ...

See the original post:

The Promise -- and Perils -- of Personalized Medicine